WP-CGR
From $71.99 / vial
For in-vitro laboratory research use only. Not for human or veterinary use.
Reference compound: Cagrilintide · CAS 1415456-99-3. Lyophilized powder, 5 mg, 10 mg. Single vial, Buy-2-Get-1 3-pack, or 10-vial lab kit. For in-vitro laboratory research use only. Not for human or veterinary use. Not for use in diagnostic or therapeutic procedures. Sold to qualified researchers aged 21+.
For in-vitro laboratory research use only. Not for human or veterinary use. Not for use in diagnostic or therapeutic procedures. Sold to qualified researchers aged 21+.
What WP-CGR is
Cagrilintide (NN9838, formerly AM833) is a long-acting, acylated analog of human amylin, a 37-amino-acid pancreatic hormone co-secreted with insulin. Sequence substitutions suppress the fibrillation that limits native amylin, and a C20 fatty-diacid provides albumin binding.
Mechanism described in the literature
Cagrilintide is described as a dual amylin and calcitonin receptor agonist (DACRA). Amylin receptors are heterodimers of the calcitonin receptor with receptor activity-modifying proteins (RAMP1–3); cagrilintide retains activity at these complexes and at the calcitonin receptor itself. The area postrema and other hindbrain nuclei are the focus of its central-signaling literature.
Research areas
- Amylin and calcitonin receptor pharmacology (CTR/RAMP complexes)
- Peptide fibrillation and formulation chemistry
- Hindbrain satiety signaling
- Co-agonism with GLP-1 receptor agonists (CagriSema literature)
- Gastric-emptying and glucagon-suppression models
Specifications
| Product code | WP-CGR |
|---|---|
| Reference compound | Cagrilintide |
| CAS number | 1415456-99-3 |
| Molecular formula | C194H314N56O55S2 |
| Molecular weight | 4409.1 g/mol |
| Composition | Long-acting acylated amylin analog (37 residues) with a C20 diacid; acetate salt |
| Form | Lyophilized powder |
| Net content options | 5 mg, 10 mg |
| Container | 3 mL clear glass vial, crimped aluminum seal, flip-off cap |
| Storage | Store sealed vials at -20 °C, protected from light and moisture. 2–8 °C is acceptable for short periods such as transit and receiving. Allow a cold vial to reach room temperature before opening to avoid condensation on the lyophilized cake. |
| Intended use | In-vitro laboratory research only |
Sizes and packs
Single vial at list price · 3-Pack = Buy 2, Get 1 Free (exactly 2× list) · 10-Vial Lab Kit = 25% off list. Select the size and pack above; the price updates.
Handling and storage
Store sealed vials at -20 °C, protected from light and moisture. 2–8 °C is acceptable for short periods such as transit and receiving. Allow a cold vial to reach room temperature before opening to avoid condensation on the lyophilized cake.
Vials ship sealed, cushioned and with a desiccant pack in plain packaging. Each vial is labeled with the product code, net content and the research-use designation. A packing slip lists the product codes and quantities ordered.
Frequently asked questions
Who can order?
Qualified researchers aged 21+ purchasing for in-vitro laboratory research. You confirm this at site entry and again at checkout.
When does it ship?
Orders confirmed by 2 PM CT ship the same business day by USPS Priority Mail (1–3 business days). Free shipping on orders over $149. Tracking is emailed when the carrier scans the label.
Can I return it?
All sales are final. Items that arrive damaged or incorrect are replaced when reported with photos within 72 hours of delivery — see Shipping & Returns.
References
- Kruse T, Hansen JL, Dahl K, et al.. Development of Cagrilintide, a Long-Acting Amylin Analogue. Journal of Medicinal Chemistry 2021. doi:10.1021/acs.jmedchem.1c00565
- Lau DCW, Erichsen L, Francisco AM, et al.. Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial. The Lancet 2021. doi:10.1016/S0140-6736(21)01751-7
- Enebo LB, Berthelsen KK, Kankam M, et al.. Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial. The Lancet 2021. doi:10.1016/S0140-6736(21)00845-X
This overview summarizes published literature about the reference compound and is provided for research context only. It is not a description of the properties, effects or uses of this product, which is supplied strictly for in-vitro laboratory research by qualified researchers. Nothing on this page is an instruction for preparation or use.
For in-vitro laboratory research use only. Not for human or veterinary use. Not for use in diagnostic or therapeutic procedures. Sold to qualified researchers aged 21+.
Available sizes and packs
| Weight | N/A |
|---|---|
| Size | 10 mg, 5 mg |
| Pack | Single vial, 3-Pack · Buy 2 Get 1 Free, 10-Vial Lab Kit |







